Sensus Healthcare Analyst Targets Diverge Amid 2026 Expectations Shift

miércoles, 11 de marzo de 2026, 12:44 pm ET1 min de lectura
SRTS--

Sensus Healthcare's analyst narrative has shifted with one price target at $7.50 and another at $6. Alliance Global is bullish on the SRT-100/Vision platform and potential reimbursement changes in 2026, while Maxim is cautious citing recent quarterly weakness and customer concentration. The company plans to introduce Sensus Link, a cloud-based software and connectivity solution, in a phased commercial rollout starting in 2026.

Sensus Healthcare Analyst Targets Diverge Amid 2026 Expectations Shift

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios